Cholesterol drug studied as abortion pill alternative

NCT ID NCT05342974

First seen Apr 22, 2026

Summary

This pilot study tested whether the cholesterol drug atorvastatin, followed by misoprostol, can safely and effectively end an early pregnancy. Nine participants at 35-49 days of pregnancy took atorvastatin daily for a week, then misoprostol. Researchers used ultrasounds and blood tests to see if the pregnancy stopped or passed. The study is complete, but results are not yet reported.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABORTION EARLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Planned Parenthood Association of Utah

    Salt Lake City, Utah, 84102, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

atorvastatin and misoprostol

What this could lead to

If it works, this could point toward a new medication abortion option without mifepristone.

What could go wrong

This is a very small, early-phase pilot study with only 9 participants. It may not work, and participants may still need a surgical procedure to complete the abortion.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.